SGL Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.69M Sell
29,360
-135
-0.5% -$31.5K 2.65% 8
2026
Q1
$6.53M Sell
29,495
-1,811
-6% -$422K 2.45% 8
2025
Q4
$7.44M Sell
31,306
-1,282
-4% -$254K 2.98% 5
2025
Q3
$6.07M Sell
32,588
-161
-0.5% -$27.6K 2.53% 10
2025
Q2
$5.1M Buy
32,749
+412
+1% +$63.3K 2.43% 11
2025
Q1
$5.03M Buy
32,337
+856
+3% +$134K 2.6% 9
2024
Q4
$4.89M Buy
31,481
+940
+3% +$146K 2.46% 14
2024
Q3
$4.64M Buy
+30,541
New +$4.87M 2.38% 13

Other funds holding JNJ

SGL Investment Advisors's JNJ Position: Q2 2026 in Review

SGL Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 0.46% in Q2 2026, selling an estimated $31.5K and leaving 29,360 shares worth $7.69M. The position accounts for 2.65% of the portfolio, ranked #8.

SGL Investment Advisors first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SGL Investment Advisors held 29,360 shares of Johnson & Johnson worth $7.69M as of Q2 2026.
  • SGL Investment Advisors sold 135 Johnson & Johnson shares in Q2 2026, an estimated $31.5K.
  • Johnson & Johnson made up 2.65% of SGL Investment Advisors's portfolio in Q2 2026, its #8 holding.
  • SGL Investment Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.